Fisher Stewart
SEC CIK 1824863 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | CSO | 131.4K | — | $3.84M | 15 | 2021-07-29 | 2024-09-16 |
Most active insiders at CCCC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | REYNO LEONARD | Chief Medical Off | — | $22.2K |
| 2 | Mahaney Paige | CSO | — | — |
| 3 | Mossler Mark | CAO | — | — |
| 4 | Adams Kendra | CFO | — | — |
| 5 | Boyle Scott N | Chief Business Off | — | — |
| 6 | Anderson Kenneth Carl | Dir | — | — |
| 7 | Schick Kelly | CHRO | — | — |
| 8 | GROGAN DONNA ROY | Dir | — | — |
| 9 | Hirsch Andrew | Pres, CEO, Dir | — | — |
Fisher Stewart made no open-market trades at CCCC in the last 12 months.
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-17 | 2024-09-16 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | M - OptEx | — | +2,250 | 131.4K | +2% | — |
| D | 2024-09-17 | 2024-09-16 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | F - Tax | $6.36 | -661 | 130.7K | -0.5% | -$4,204 |
| D | 2024-02-15 | 2024-02-14 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | A - Grant | $0.00 | +27.3K | 129.1K | +27% | $0 |
| D | 2024-02-15 | 2024-02-13 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | F - Tax | $6.53 | -2,255 | 101.8K | -2% | -$14.7K |
| D | 2023-08-31 | 2023-08-30 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | F - Tax | $2.93 | -661 | 104.1K | -0.6% | -$1,937 |
| D | 2023-08-31 | 2023-08-30 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | M - OptEx | — | +2,250 | 104.7K | +2% | — |
| D | 2023-02-15 | 2023-02-13 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | A - Grant | $0.00 | +26.0K | 102.5K | +34% | $0 |
| D | 2023-02-01 | 2023-01-30 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | M - OptEx | — | +3,750 | 77.8K | +5% | — |
| D | 2023-02-01 | 2023-01-30 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | F - Tax | $7.78 | -1,301 | 76.5K | -2% | -$10.1K |
| A | 2022-06-14 | 2022-05-26 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | F - Tax | $7.01 | -1,102 | 74.0K | -1% | -$7,725 |
| D | 2022-05-27 | 2022-05-25 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | M - OptEx | — | +3,750 | 75.1K | +5% | — |
| DM | 2022-04-12 | 2022-04-12 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | M - OptEx | $4.88 | +28.1K | 45.5K | +162% | +$137.1K |
| DM | 2021-12-10 | 2021-12-08 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | M - OptEx | $3.55 | +20.6K | 25.1K | +451% | +$73.0K |
| 2021-08-05 | 2021-08-03 | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | S - Sale | $45.01 | -17.1K | 22.7K | -43% | -$767.7K | |
| M | 2021-08-02 | 2021-07-29+ | CCCC | C4 Therapeutics, Inc. | Fisher Stewart | CSO | S - Sale | $45.00 | -68.3K | 39.8K | -63% | -$3.07M |
Purchase Sale Sale after option exercise All abbreviations